Outcomes of cardiac myosin inhibitors in hypertrophic cardiomyopathy: an updated brief meta-analysis
International Journal of Cardiology and Cardiovascular Diseases · 25.05.2026 · 6 (1) · 41
DOI: 10.46439/cardiology.6.039 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Cardiology and Cardiovascular Diseases, online erschienen am 25.05.2026. Verfasst von Joud Fahed und 6 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Fahed, J., Rab, A. U., Hamza, M., Afraz, R., Awad, A., Riahi, A. M. A., & Upreti, P. (2026). Outcomes of cardiac myosin inhibitors in hypertrophic cardiomyopathy: an updated brief meta-analysis. International Journal of Cardiology and Cardiovascular Diseases, 6(1), 41. https://doi.org/10.46439/cardiology.6.039
Vancouver
Fahed J, Rab AU, Hamza M, Afraz R, Awad A, Riahi AMA, et al. Outcomes of cardiac myosin inhibitors in hypertrophic cardiomyopathy: an updated brief meta-analysis. International Journal of Cardiology and Cardiovascular Diseases. 2026;6(1):41. doi:10.46439/cardiology.6.039
BibTeX
@article{Fahed2026,
author = {Fahed, Joud and Rab, Asad Ur and Hamza, Mohammad and Afraz, Rehman and Awad, Ali and Riahi, Abdul Monem Al and Upreti, Prakash},
title = {Outcomes of cardiac myosin inhibitors in hypertrophic cardiomyopathy: an updated brief meta-analysis},
journal = {International Journal of Cardiology and Cardiovascular Diseases},
year = {2026},
volume = {6},
number = {1},
pages = {41},
doi = {10.46439/cardiology.6.039}
}
EUVIMED